Edwards Lifesciences
1,240 hedge funds and large institutions have $42.4B invested in Edwards Lifesciences in 2022 Q3 according to their latest regulatory filings, with 109 funds opening new positions, 445 increasing their positions, 457 reducing their positions, and 118 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,240
Holders Change
-26
Holders Change %
-2.05%
% of All Funds
21.44%
Holding in Top 10
18
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-18.18%
% of All Funds
0.31%
New
109
Increased
445
Reduced
457
Closed
118
Calls
$189M
Puts
$130M
Net Calls
+$58.6M
Net Calls Change
+$71.6M
Top Buyers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$566M |
| 2 |
Millennium Management
New York
|
+$187M |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$182M |
| 4 |
Amundi
Paris,
France
|
+$101M |
| 5 |
Holocene Advisors
New York
|
+$80.6M |
Top Sellers
| 1 |
BlackRock
New York
|
-$276M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$185M |
| 3 |
Schroder Investment Management Group
London,
United Kingdom
|
-$161M |
| 4 |
Bank of New York Mellon
New York
|
-$113M |
| 5 |
Sands Capital Management
Arlington,
Virginia
|
-$108M |
